<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160824029512N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-16</date_registration>
      <primary_sponsor>Torbate-Heidaria University of Medical Sciences</primary_sponsor>
      <public_title>King's Theory Based Educational Program for Improving Self Efficacy in Diabetic Patients</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the Effect of an Educational Intervention Based on King's Theory of Goal Attainment on Self-Efficacy and Self-Care Behaviors in Patients with Type 2 Diabetes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-06-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68100</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Other design features: A two arm parallel group randomized controlled trial with pre test post test design and three month follow up. Eighty patients with type 2 diabetes will be randomly allocated to intervention group (four week educational program based on King's Theory constructs including personal system, interpersonal system, social system and transaction) and control group (standard care). The study employs single blinding (outcome assessors and data analysts blinded), Randomization description: In this study,  randomization at the individual level will be utilized to maintain a precise balance between the two groups throughout the recruitment period, and given this approach, no stratification will be applied. The random sequence will be generated using the random number generation function in Microsoft Excel software. To allocate 80 patients into two groups of 40 each, 20 blocks of four will be used. Within each block, two allocations are assigned to the intervention group and two to the control group, and their sequence will be completely randomized using the RAND function in Excel. This ensures that exactly 40 patients will ultimately be placed in each group, and no quasi-randomization methods, such as allocation based on the date of visit, medical record number, or alternation, will be employed. Regarding allocation concealment, which is a distinct process from blinding and is aimed at preventing selection bias, the standard method of sequentially numbered, opaque, sealed envelopes (SNOSE) will be implemented. The sequence generated in Excel will be written on identical cards and placed inside opaque envelopes so that the contents cannot be seen from the outside. The envelopes will then be sealed and numbered sequentially from 1 to 80, strictly according to the random sequence order, and kept securely by the principal investigator in a safe location. After verifying the inclusion criteria and obtaining written informed consent from each patient, the researcher will open the lowest available numbered envelope to determine the assigned group. Prior to opening the envelope, the next assignment will remain completely concealed and unpredictable to both the researcher and the patient, Blinding description: Due to the educational nature of intervention, blinding of participants and interventionist is not feasible. Outcome assessors (data collectors) and data analysts will be blinded to group allocation status.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Type 2 diabetes mellitus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants receiving a four-week educational program based on King's Theory of Goal Attainment, consisting of four weekly 90-minute group sessions with a maximum of 8 participants per group. Week 1 (Personal System): enhancing self-efficacy through identification of personal barriers, setting SMART goals for diabetes self-management, and mental imagery exercises for successful health behaviors. Week 2 (Interpersonal System): improving interaction with healthcare providers via role-playing simulated consultations with physicians and nurses, and training effective communication skills for expressing treatment needs. Week 3 (Social System): engaging family members in diabetes management, developing social support mapping, and resolving conflicts related to dietary and medication adherence. Week 4 (Purposeful Transaction): integrating all three systems into an individualized action plan, providing group feedback, and establishing a 3-month follow-up schedule. Educational methods include structured group discussion, role-playing exercises, case study analysis, and immediate feedback delivered by a nurse trained in King's Theory application.Control group: Participants receiving standard diabetes care consisting of a single 45-minute individual counseling session delivered by a center nurse, covering general principles of dietary management for type 2 diabetes, instructions on antidiabetic medication use (metformin, sulfonylureas), importance of regular blood glucose monitoring (fasting and postprandial), and basic recommendations for age-appropriate physical activity. This session lacks theoretical framework, interactive components, or repeated educational contacts. Participants retain access to routine primary care services (regular physician and nurse visits) throughout the study period. Intervention 2: Control group: Receiving standard diabetes care including single session general counseling on diet, anti diabetic medications and importance of blood glucose control without structured content based on King's Theory.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Study protocol and statistical analysis plan: The complete study protocol including objectives, methodology, inclusion/exclusion criteria, randomization and blinding procedures, and the statistical analysis plan detailing descriptive and inferential methods (independent and paired t-tests, analysis of covariance),all data , questionnaires will be made available six months after publication of the primary manuscript. The data dictionary will include variable definitions, measurement scales, and coding schemes used in questionnaires. The final clinical study report will be disseminated through publication in a peer-reviewed scientific journal.
Availability timeframe: Six months after publication of the primary manuscript and until the end of the third year following study completion.
Authorized recipients: Researchers holding valid ethics approval from an accredited academic institution with research objectives related to diabetes or health education.
Access conditions: Submission of written request with research proposal and institutional ethics approval to the principal investigator; use strictly for non-commercial research purposes with proper citation of the original study.
Request mechanism: Email request to the principal investigator (Dr. Mohammad Hossein Delshad) at delshad264@gmail.com including institutional affiliation and research purpose.

When:
Six months after publication of the primary manuscript until the end of the third year following study completion

To whom:
Researchers holding valid ethics approval from accredited academic and research institutions (universities and research centers under the supervision of the Ministry of Science or Ministry of Health) with research objectives related to diabetes, health education, or health psychology, requesting access solely for non-commercial research purposes.

Conditions:
De-identified data and study documents may be used only for non-commercial academic research and educational purposes. Conditions for use include:  

    Submission of valid institutional ethics approval from the requesting organization  
    Provision of a research proposal related to diabetes, health education, or health psychology  
    Mandatory citation of the original study in any resulting publications or presentations  
    Prohibition of commercial use, marketing activities, or attempts to re-identify participants  
    No redistribution of data to third parties without written permission from the principal investigator

Where to obtain:
Principal Investigator: Dr. Mohammad Hossein Delshad, Assistant/Associate Professor, Department of Public Health, Research Center for Health Sciences, School of Public Health, Torbat Heydariyeh University of Medical Sciences
Postal Address: Research Center for Health Sciences, School of Public Health, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Razavi Khorasan Province, Iran, Postal Code: 9417966579
Official Institutional Email: delshad@thums.ac.ir
Office Phone: +98 51 52421 ext. 248(if applicable)

How to obtain:
The data request process follows four sequential steps:
Step 1) Submission of written request via institutional email including research proposal, valid ethics approval certificate, and institutional letter of introduction to the principal investigator's official email address;
Step 2) Review by the Study Data Access Committee (comprising the principal investigator and two independent faculty members) within 15 working days;
Step 3) Upon approval, signing of a Data Use Agreement that legally prohibits commercial use and any attempt to re-identify participants;
Step 4) Delivery of de-identified data in Excel or SPSS format within 10 working days after agreement execution.
The entire process typically takes 25 to 35 working days from initial submission to data delivery. Incomplete requests or those lacking valid ethics approval will be rejected without review.

Comments:
Raw data containing personally identifiable information (name, medical record number, contact details) will be permanently deleted immediately after initial coding; only de-identified coded data will be retained for analysis. No fees will be charged to participants and participation is entirely voluntary. The study has no financial or organizational conflicts of interest and is fully funded by the Vice-Chancellor for Research and Technology of Torbat Heydariyeh University of Medical Sciences. All study procedures are conducted under the supervision of the University Ethics Committee (Code: IR.THUMS.REC.1401.036).</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad hossien Delshad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ferdowsi St. Razi Razi St. 2, No. 14, 2nd floor</address>
        <city>Torbat Heydariyeh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9519633885</zip>
        <telephone>+98 51 5222 1508</telephone>
        <email>h.delshad@modares.ac.ir</email>
        <affiliation>Torbate-Heidaria University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad hossien Delshad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ferdowsi St. Razi Razi St. 2, No. 14, 2nd floor</address>
        <city>Torbat Heydariyeh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9519633885</zip>
        <telephone>+98 51 5222 1508</telephone>
        <email>h.delshad@modares.ac.ir</email>
        <affiliation>Torbate-Heidaria University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with type 2 diabetes
Age between 30 and 70 years
Providing written informed consent
Ability to read and comprehend questionnaires
Attendees of selected comprehensive health service centers</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of severe psychiatric disorders
Advanced cardiac or renal failure
Recent surgery less than three months ago
Unwillingness to continue participation throughout the study period</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Type 2 diabetes mellitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants receiving a four-week educational program based on King's Theory of Goal Attainment, consisting of four weekly 90-minute group sessions with a maximum of 8 participants per group. Week 1 (Personal System): enhancing self-efficacy through identification of personal barriers, setting SMART goals for diabetes self-management, and mental imagery exercises for successful health behaviors. Week 2 (Interpersonal System): improving interaction with healthcare providers via role-playing simulated consultations with physicians and nurses, and training effective communication skills for expressing treatment needs. Week 3 (Social System): engaging family members in diabetes management, developing social support mapping, and resolving conflicts related to dietary and medication adherence. Week 4 (Purposeful Transaction): integrating all three systems into an individualized action plan, providing group feedback, and establishing a 3-month follow-up schedule. Educational methods include structured group discussion, role-playing exercises, case study analysis, and immediate feedback delivered by a nurse trained in King's Theory application.Control group: Participants receiving standard diabetes care consisting of a single 45-minute individual counseling session delivered by a center nurse, covering general principles of dietary management for type 2 diabetes, instructions on antidiabetic medication use (metformin, sulfonylureas), importance of regular blood glucose monitoring (fasting and postprandial), and basic recommendations for age-appropriate physical activity. This session lacks theoretical framework, interactive components, or repeated educational contacts. Participants retain access to routine primary care services (regular physician and nurse visits) throughout the study period.</i_keyword>
      <i_keyword>Control group: Receiving standard diabetes care including single session general counseling on diet, anti diabetic medications and importance of blood glucose control without structured content based on King's Theory.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Self efficacy score for diabetes management. Timepoint: Pre test before intervention onset, post test immediately after completion of four week educational program, and three month follow up after intervention completion. Method of measurement: Diabetes Self Efficacy Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Diabetes self care behaviors. Timepoint: Before, after and  3-month follow-up after intervention. Method of measurement: Summary of Diabetes Self Care Activities questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Torbate-Heidaria University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-13</approval_date>
        <contact_name>Torbat Heydariyeh Medical Sciences</contact_name>
        <contact_address>Torbat Heydariyeh, North Ferdowsi St., Razi Razi 2, No. 14, 2nd floor Torbat Heydariyeh Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
